Additional Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Sacramento CA. 95817
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Loma Linda CA. 92350
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Phoenix AZ. 85032
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Philadelphia PA. 19140
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Kansas City KS. 66160
    View Details

  • Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease

    Maule Stem Cell Research Institute
    Venice FL. 34292
    View Details

  • A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis

    Pulmonary Medicine Consultants
    McKinney TX. 75071
    View Details

  • A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis

    Innova Pharma Research
    Doral FL. 33172
    View Details

  • A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis

    New Life Medical Research
    Hialeah FL. 33012
    View Details

  • A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis

    New Access Research and Medical Services
    Miami FL. 33186
    View Details

  • A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis

    VALDI
    Fresno CA. 93720
    View Details

  • A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis

    Palmtree Clinical Research
    Palm Springs CA. 92262
    View Details

  • A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis

    Low Country Research
    Charleston SC. 29406
    View Details

  • A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis

    Southeastern Research Center
    Winston-Salem NC. 27103
    View Details

  • A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis

    Metroplex Pulmomary & Sleep Center
    McKinney TX. 75069
    View Details

  • A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

    UCLA Health Westwood Medical Plaza
    Westwood CA. 90095
    View Details

  • A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

    Florida Lung, Asthma & Sleep Specialists/Clinical Research Specialists, LLC
    Kissimmee FL. 34746
    View Details

  • A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

    Memorial Sloan Kettering Westchester (Limited Protocol Activities)
    Harrison NY. 10604
    View Details

  • A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

    Memorial Sloan Kettering Nassau (Limited Protocol Activities)
    Uniondale NY. 11553
    View Details

  • A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
    New York NY. 10065
    View Details